$ATEC

A spine-surgery company will discuss its third-quarter results live Oct. 29

Alphatec Holdings (ATEC) will report Q3 2026 results on Oct 29 after market close. A live webcast at 4:30 p.m. ET will follow, with a Q&A session for registered analysts. A replay will be available for 12 months. ATEC focuses on innovative spine surgery solutions.

Original reporting
Published Oct 19, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ATEC
Neutral
medium confidence
Mentioned
$ATEC
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$ATECNeutralLow
01

Why it matters

The upcoming earnings call provides a timing cue for traders to position ahead of potential volatility, but no new financial metrics are disclosed.

02

Market read

The announcement is a routine earnings reminder with limited immediate trading impact, primarily useful for pre-earnings positioning.

03

What to watch

Analyst expectations and prior quarter performance may already be baked into the stock price.

Relevance 4/10Novelty 2/10Timing: pre-market Oct 29

Background

Alphatec Holdings (ATEC) is a medical device company focused on spine surgery solutions. The company regularly schedules earnings calls to discuss quarterly performance.

Company-level read

Ticker impact

$ATECNeutralMedium confidence
Context

Alphatec Holdings announced it will report Q3 2026 results on Oct. 29 after market close.

Expected impact

potential volatility; direction uncertain pending earnings numbers

Evidence & confidence

The announcement is a standard earnings reminder without new financial data, so price movement will depend on the actual results.

Market effects

None significant; the notice is specific to Alphatec and does not affect the broader medical device sector.

Limited to U.S. investors tracking Nasdaq-listed medical device stocks.

Low; no global macro or sector-wide implications.

Counterpoint

If the market has already priced in strong earnings, the reminder could trigger a sell-off on disappointment.

Key entities

  • Alphatec Holdings, Inc.

    Nasdaq-listed medical device firm specializing in spine surgery.

Related articles

$ATECMedAI 8/10

Alphatec Q3 Earnings Call Highlights

Alphatec reported Q3 earnings with higher margins (72%) and positive free cash flow ($6M). Full-year 2026 revenue guidance was reduced to $862M due to market softness and supply constraints. The company highlighted growth in EOS and Valence platforms. Alphatec ended the quarter with $135M in liquidity.

$ATECMedAI 8/10

ATEC Reports Third Quarter Financial Results – Ortho Spine News

Alphatec Holdings (ATEC) reported Q3 2026 revenue of $221M, up 13% YoY, with surgical revenue at $202M, up 14%. Adjusted EBITDA was $38M, or 17% of revenue, up 400 bps YoY. Case volumes grew 20% and new surgeon users increased 25%. The company expects full-year 2026 revenue of $862M, adjusted EBITDA of $137M, and $10M in free cash flow.

$ATECMedAI 8/10

Alphatec: Q3 Earnings Snapshot

Alphatec Holdings Inc. (ATEC) reported a Q3 loss of $5.5 million, or 3 cents per share, with adjusted earnings of 9 cents per share. Revenue was $221.2 million, missing estimates of $224.3 million. The company expects full-year revenue of $862 million. ATEC shares have fallen 46% YTD and 31% over the past year.